Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world’s leading cause of disability, in...

Full description

Bibliographic Details
Main Authors: Antonietta Vilella, Barbara Ruozi, Daniela Belletti, Francesca Pederzoli, Marianna Galliani, Valentina Semeghini, Flavio Forni, Michele Zoli, Maria Angela Vandelli, Giovanni Tosi
Format: Article
Language:English
Published: MDPI AG 2015-06-01
Series:Pharmaceutics
Subjects:
nanomedicine
blood brain barrier
neuron
endocytosis
cellular uptake
Online Access:http://www.mdpi.com/1999-4923/7/2/74

Internet

http://www.mdpi.com/1999-4923/7/2/74

Similar Items